The pathophysiology and pharmacological treatment of Huntington disease.
Pidgeon, Connie
The pathophysiology and pharmacological treatment of Huntington disease. [electronic resource] - Behavioural neurology 2013 - 245-53 p. digital
Publication Type: Journal Article; Review; Systematic Review
1875-8584
10.3233/BEN-2012-120267 doi
Antidepressive Agents--therapeutic use
Antipsychotic Agents--therapeutic use
Basal Ganglia--drug effects
Cannabinoids--therapeutic use
Cholinesterase Inhibitors--therapeutic use
Excitatory Amino Acid Antagonists--therapeutic use
GABA Agonists--therapeutic use
Humans
Huntington Disease--drug therapy
Neuroprotective Agents--therapeutic use
Tetrabenazine--therapeutic use
The pathophysiology and pharmacological treatment of Huntington disease. [electronic resource] - Behavioural neurology 2013 - 245-53 p. digital
Publication Type: Journal Article; Review; Systematic Review
1875-8584
10.3233/BEN-2012-120267 doi
Antidepressive Agents--therapeutic use
Antipsychotic Agents--therapeutic use
Basal Ganglia--drug effects
Cannabinoids--therapeutic use
Cholinesterase Inhibitors--therapeutic use
Excitatory Amino Acid Antagonists--therapeutic use
GABA Agonists--therapeutic use
Humans
Huntington Disease--drug therapy
Neuroprotective Agents--therapeutic use
Tetrabenazine--therapeutic use